Picture of InnovAge Holding logo

INNV InnovAge Holding Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Annual income statement for InnovAge Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue466567638699688
Cost of Revenue
Gross Profit111141174135101
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses429516665703737
Operating Profit36.550.9-26.8-4.41-49.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes25.435.6-35-7.24-50.8
Provision for Income Taxes
Net Income After Taxes19.125.8-44.7-7.96-43.6
Minority Interest
Net Income Before Extraordinary Items
Net Income19.626.3-44-6.52-40.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income19.626.3-44-6.52-40.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.1870.2380.0760.054-0.168
Dividends per Share